BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:JNJ-95597528 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of JNJ-95597528\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07746687-1400@assetmemo.bio
DTSTAMP:20261121T010133Z
DTSTART;VALUE=DATE:20290911
DTEND;VALUE=DATE:20290912
SUMMARY:JNJ-95597528: Phase 2 readout est. (NCT07746687)
DESCRIPTION:JNJ-95597528\, phase 2.\nStudy: A Study of JNJ-95597528 in Part
 icipants With Inadequately Controlled Moderate to Severe Asthma\nEstimated
  primary completion: 11 September 2029. This is a ClinicalTrials.gov estim
 ate\, not a confirmed readout date\, and it can move.\nDrug page: https://
 assetmemo.bio/drug/jnj-95597528#upcoming-events\nRegistry record: https://
 clinicaltrials.gov/study/NCT07746687
URL:https://assetmemo.bio/drug/jnj-95597528#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
